Inass Shaltout

Incretins beyond weight and hyperglycemia management: a consensus statement by AASD

Abstract Background The global prevalence of obesity continues to rise, with 3 billion adults projected to be affected by 2030. Recent advances in anti-obesity pharmacotherapy, particularly incretin-based medications, have transformed obesity management. This consensus provides e...